<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00323128</url>
  </required_header>
  <id_info>
    <org_study_id>2006/037</org_study_id>
    <nct_id>NCT00323128</nct_id>
  </id_info>
  <brief_title>Validation of Serum Creatinine Dosage and Renal Clearance</brief_title>
  <official_title>Validation of Serum Creatinine Dosage and Renal Clearance</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Ghent</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Ghent</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study has an open study design. The GFR will be measured using the renal clearance of
      inulin (Inutest) in volunteers with different stage of renal disease or without renal
      disease. A blood sample will be obtained for measuring serum creatinine in different
      laboratories.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In this study we will investigate the correlation between the GFR as measured by inulin
      clearance (golden standard) and the estimated GFR as measured by laboratories which used
      different serum creatinine assays in patients without renal disease and in patients with
      different stage of kidney failure.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>May 2006</start_date>
  <completion_date type="Actual">December 2010</completion_date>
  <primary_completion_date type="Actual">April 2008</primary_completion_date>
  <phase>Phase 1</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Non-Randomized</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Glomerular filtration ratio</measure>
    <time_frame>At time T0</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Serum creatinine</measure>
    <time_frame>At time T0</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Kidney Failure</condition>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Calculation of inuline clearance</intervention_name>
    <description>Calculation of inuline clearance.</description>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Measuring serum creatinine</intervention_name>
    <description>Measuring serum creatinine.</description>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Normal weight as defined by a Body Mass Index of 18 to 30 kg/m2.

          -  Subject is competent and willing to sign informed consent form after being given all
             the detailed information about the study. Informed consent form signed voluntarily.

          -  The subjects must be in stable clinical condition, with stable serum creatinin at
             least for 6 months.

          -  Persons with different stage of chronic renal disease and without kidney disease
             (living donors) who need an evaluation of the GFR or Admitted volunteers who easily
             obtain urine samples.

        Exclusion Criteria:

          -  Transplant patients

          -  Medication that will influence the serumcreatinine.

          -  Morbid obesity

          -  Pregnant, lactating females or females with childbearing potential without adequate
             contraception (use of oral contraceptives, IUD or condoms with spermicide).

          -  History of allergy or hypersensitivity to inulin

          -  Donation of blood in the 60 days preceding the first visit.

          -  Liver disease, heart failure, nephrotic syndrome.

          -  Patients in critically ill conditions.

          -  Malnutrition

          -  Postrenal kidney failure
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>60 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Raymond Van Holder, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Ghent</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Arjan Van der Tol, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Ghent</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Algemeen Stedelijk Ziekenhuis Aalst</name>
      <address>
        <city>Aalst</city>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location>
    <facility>
      <name>University Hospital Ghent</name>
      <address>
        <city>Ghent</city>
        <zip>9000</zip>
        <country>Belgium</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Belgium</country>
  </location_countries>
  <link>
    <url>http://www.uzgent.be</url>
    <description>Website University Hospital Ghent</description>
  </link>
  <verification_date>June 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 8, 2006</study_first_submitted>
  <study_first_submitted_qc>May 8, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 9, 2006</study_first_posted>
  <last_update_submitted>June 1, 2011</last_update_submitted>
  <last_update_submitted_qc>June 1, 2011</last_update_submitted_qc>
  <last_update_posted type="Estimate">June 2, 2011</last_update_posted>
  <responsible_party>
    <name_title>Arjan Van Der Tol</name_title>
    <organization>University Hospital Ghent</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Renal Insufficiency</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

